The function of PML in p53-dependent apoptosis

Nature Cell Biology

Volumn 2, Issue 10, 2000, Pages 730-736

  Guo, Ailan ^a   Salomoni, Paolo ^a   Luo, Jianyuan ^b   Shih, Alan ^a   Zhong, Sue ^a   Gu, Wei ^b   Pandolfi, Pier Paolo ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; DNA DAMAGE; GAMMA IRRADIATION; GENE FUNCTION; GENE INDUCTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DNA BINDING; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMAL; APOPTOSIS; CELL COMPARTMENTATION; CELL NUCLEUS; DNA DAMAGE; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; MICE, MUTANT STRAINS; NEOPLASM PROTEINS; PROTEIN P53; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; THYMUS GLAND; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0034306019     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/35036365     Document Type: Article

References (47)

1. Pandolfi, P. P. et al. Structure and origin of the acute promyelocytic leukemia myl/RARalpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6, 1285-1292 (1991).
2. de The, H. et al. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684 (1991).
3. Kakizuka, A. et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARalpha with a novel putative transcription factor, PML. Cell 66, 663-674 (1991).
4. Goddard, A. D., Borrow, P. S., Freemont, P. S. & Solomon, E. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science 254, 1371-1374 (1991).
5. Melnick, A. & Licht, J. D. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93, 3167-3215 (1999).
6. He, L-Z., Merghoub, T. & Pandolfi, P. P. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications. Oncogene 18, 5278-5292 (1999).
7. Kastner, P. et al. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11, 629-642 (1992).
8. Perez, A. et al. PML/RAR homodimers: distinct DNA binding properties and heteromeric interactions with RAR. EMBO J. 12, 3171-3182 (1993).
9. Borden, K. L. B. et al. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J. 14, 1532-1541 (1995).
10. Zhong, S., Salomoni, P. & Pandolfi, P. P. The transcriptional role of PML and the nuclear body. Nature Cell Biol. 2, E85-E90 (2000).
11. Zhong, S. et al. Role of Sumo-1-modified PML in nuclear body formation. Blood 95, 2748-2753 (2000).
12. Wang, Z. G. et al. Role of PML in cell growth and the retinoic acid pathway. Science 279, 1547-1551 (1998).
13. Wang, Z G. et al. Pml is essential for multiple apoptotic pathways. Nature Genet. 20, 266-271 (1998).
14. Ahn, J. H., Brignole, E. & Hayward, G. S. Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol. Cell Biol. 18, 4899-4913 (1998).
15. Zhong, S. et al. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Nature Genet. 23, 287-295 (1999).
16. Doucas, V., Tini, M., Egan, D. A. & Evans, R. M. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl Acad. Sci. USA 96, 2627-2632 (1999).
17. Rachez, C. et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398, 824-828 (1999).
18. Näär, A. M. et al. Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature 398, 828-832 (1999).
19. Fondell, J. D., Ge, H. & Roeder, R. G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl Acad. Sci. USA 93, 8329-8333 (1996).
20. Ko, L. J. & Prives, C. p53: puzzle and paradigm. Genes Dev. 10, 1054-1072 (1996).
21. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997).
22. Hollstein, M. et al. Database of somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22, 3551-3555 (1994).
23. Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356, 215-221 (1992).
24. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A. & Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-849 (1993).
25. Clarke, A. R. et al. Thymocyte apoptosis induced by p53-dependent and -independent pathways. Nature 362, 849-852 (1993).
26. Chao, D. T. & Korsmeyer, S. J. BCL-2 family: regulators of cell death. Annu. Rev. Immunol. 16, 395-419 (1998).
27. Hodges, M., Tissot, C., Howe, K., Grimwade, D. & Freemont, P. S. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am. J. Hum. Genet. 63, 297-304 (1998).
28. Masuda, H., MIller, C., Koeffler, H. P., Battifora, H. & Cline, M. J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl Acad. Sci. USA 84, 7716-7719 (1987).
29. El-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-25 (1993).
30. Miyashita, T. R. J. C. Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 80, 293-299 (1995).
31. Hollander, M. C. et al. Analysis of the mammalian gadd45 gene and its response to DNA damage. J. Biol. Chem. 268, 24385-24393 (1993).
32. Gu, W., Shi, X. L. & Roeder R. G. Synergistic activation of transcription by CBP and p53. Nature 387, 819-823 (1997).
33. LaMorte, V. J., Dyck, J. A., Ochs, R. L. & Evans, R. M. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl Acad. Sci. USA 95, 4991-4996 (1998).
34. Gu, W. & Roeder, R. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606 (1997).
35. Zhao, R. et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrarys. Genes Dev. 14, 981-993 (2000).
36. Yu, J. et al. Identification and classification of p53-regulated genes. Proc. Natl Acad. Sci. USA. 96, 14517-14522 (1999).
37. Bouvard, V. et al. Tissue and cell-specific expression of the p53-target genes: Bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice. Oncogene 19, 649-660 (2000).
38. Zhong, S. et al. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. J. Exp. Med. 191, 631-639 (2000).
39. Strasser, A., Harris, A. W., Jacks, T. & Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79, 329-339 (1994).
40. Sakaguchi, K. et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12, 2831-2841 (1998).
41. Liu, L. et al. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell Biol. 19, 1202-1209 (1999).
42. MacLachlan, T. K. et al. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J. Biol. Chem. 275, 2777-2785 (2000).
43. Reap, E. A. et al. Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interactions. Proc. Natl Acad. Sci. USA 94, 5750-5755 (1997).
44. Zhong, S. et al. A role for PML and the nuclear body in genomic stability. Oncogene 18, 7941-7947 (1999).
45. Grignani, F. et al. The acute promyelocytic leukemia specific PML/RARα fusion protein inhibits differentiation and promotes suvival of myeloid precursor cells. Cell 74, 423-431 (1993).
46. Longo, L. et al. Frequency of RAS and p53 mutations in acute promyelocytic leukemias. Leuk. Lymphoma 11, 405-410 (1993).
47. Gaiddon, C., Moorthy, N. C. & Prives, C. Ref-1 regulates the transactivation and the pro-apoptotic function of p53 in vivo. EMBO J. 18, 5609-5621 (1999).